platinum has been researched along with Anal Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Anandappa, G; Arnold, D; Capdevila, J; Catlett, M; Cornfeld, M; Dahan, L; Demols, A; Evesque, L; Fakih, M; Gilbert, DC; Guren, MG; Jensen, LH; Kayyal, T; Kim, S; Rao, S; Samalin, E; Saunders, MP; Smith, M; Spano, JP; Spindler, KL; Tamberi, S; Tian, C | 1 |
| Baratelli, C; Chau, I; Cunningham, D; Kalaitzaki, E; Morano, F; Rao, S; Sclafani, F; Starling, N; Watkins, D | 1 |
| Couvelard, A; Gillet, A; Goujon, G; Hammel, P; Hentic, O; Lévy, P; Maire, F; Palazzo, M; Rebours, V; Ruszniewski, P; Zappa, M | 1 |
1 trial(s) available for platinum and Anal Cancer
| Article | Year |
|---|---|
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202).
Topics: Anal Canal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Anus Neoplasms; Carcinoma, Squamous Cell; Humans; Immune Checkpoint Inhibitors; Platinum | 2022 |
2 other study(ies) available for platinum and Anal Cancer
| Article | Year |
|---|---|
Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.
Topics: Adult; Aged; Anus Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Platinum; Prognosis; Pyrimidines | 2017 |
FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Pelvic Neoplasms; Platinum; Treatment Outcome | 2012 |